A development by Rainham Steel Investments Ltd

Avocet Distribution Park has the benefit of an Outline Consent for B1, B2 and B8 uses. The park can offer a range of unit sizes on a Build to Suit basis and the owners and developers Rainham Steel Investments Ltd will fully fund all development on the park.

Development Team

Rainham Steel Investments Ltd, established in 1987, wholly owns and operates a significant UK commercial property portfolio. Recent acquisitions, particularly along the Thames Corridor, have resulted in assets that are currently valued in excess of £105m
The Marick team have an extensive track record of masterplanning and managing both build-to-suit and speculative development in all aspects of the built environment, including all class uses of industrial, leisure and commercial offices, having been active in these sectors throughout England & Wales over the last 20 years. The team have been involved in approximately 12 million sq ft of development for a variety of investors, Local Authority Partnerships and occupiers.

Marick have extensive skills in occupier transactions with track record acting as both Developer and Project Manager for companies such as:

Aviva Life & Pensions
Estee Lauder
Lear Corporation
Legal & General
O2
Nissan
Scottish Widows
Standard Life
Stanley Power Tools
Win canton

Click to download INDUSTRIAL SERVICES.pdf

Hale Architecture bring together extensive experience in architecture, development and design management, addressing the needs of the commercial property sector.

Working directly for Property Investment Institutions, Property Development Companies and also Occupiers, Directors Roland Lee and Paul Hartley, head up a team focused on all aspect of architecture from initial feasibility studies through to delivery on site.

Typical project sectors include:

Mixed use

Retail parks, offices (new build and refurbishment) and out of town business parks.

Industrial

All forms including warehousing, logistics, storage and distribution.

Technology

Data centres, research and development and pharmaceutical.